These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31618309)

  • 1. Hepatitis E seroprevalence and associated risk factors in Croatian liver transplant recipients.
    Mrzljak A; Dinjar-Kujundzic P; Vilibic-Cavlek T; Jemersic L; Prpic J; Dakovic-Rode O; Kolaric B; Vince A
    Rev Soc Bras Med Trop; 2019; 52():e20190302. PubMed ID: 31618309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
    Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
    Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy.
    Scotto G; Aucella F; Grandaliano G; Martinelli D; Querques M; Gesuete A; Infante B; Carri PD; Massa S; Salatino G; Bulla F; Fazio V
    World J Gastroenterol; 2015 Mar; 21(11):3266-73. PubMed ID: 25805933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of hepatitis E in patients on haemodialysis in Croatia.
    Mrzljak A; Dinjar-Kujundzic P; Knotek M; Kudumija B; Ilic M; Gulin M; Zibar L; Hrstic I; Jurekovic Z; Kolaric B; Jemersic L; Prpic J; Tomljenovic M; Vilibic-Cavlek T
    Int Urol Nephrol; 2020 Feb; 52(2):371-378. PubMed ID: 31894559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the hepatitis E assay-dependent seroprevalence among Croatian blood donors.
    Miletić M; Vuk T; Hećimović A; Stojić Vidović M; Jemeršić L; Jukić I
    Transfus Clin Biol; 2019 Nov; 26(4):229-233. PubMed ID: 31277986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis E virus RNA and antibodies in a cohort of kidney transplant recipients in Central Brazil.
    de Oliveira JMNS; Freitas NR; Teles SA; Bottino FO; Lemos AS; de Oliveira JM; de Paula V; Pinto MA; Martins RMB
    Int J Infect Dis; 2018 Apr; 69():41-43. PubMed ID: 29408465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study.
    Harrison A; Scobie L; Crossan C; Parry R; Johnston P; Stratton J; Dickinson S; Ellis V; Hunter JG; Prescott OR; Madden R; Lin NX; Henley WE; Bendall RP; Dalton HR
    J Med Virol; 2013 Feb; 85(2):266-71. PubMed ID: 23169048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients.
    Rossi-Tamisier M; Moal V; Gerolami R; Colson P
    J Clin Virol; 2013 Jan; 56(1):62-4. PubMed ID: 23089569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis E seroprevalence in the United States: Results for immunoglobulins IGG and IGM.
    Cangin C; Focht B; Harris R; Strunk JA
    J Med Virol; 2019 Jan; 91(1):124-131. PubMed ID: 30168589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors of de novo hepatitis E virus infection after receiving liver transplantation.
    He P; Li J; Wang C; Zhang J; Jiang Y; Liu H; Zhao Y; Li Z; Gao Y; Wang Y
    J Med Virol; 2024 Oct; 96(10):e29939. PubMed ID: 39360633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection.
    Riveiro-Barciela M; Buti M; Homs M; Campos-Varela I; Cantarell C; Crespo M; Castells L; Tabernero D; Quer J; Esteban R; Rodriguez-Frías F
    PLoS One; 2014; 9(7):e103028. PubMed ID: 25068388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital].
    Aydın NN; Ergünay K; Karagül A; Pınar A; Us D
    Mikrobiyol Bul; 2015 Oct; 49(4):554-64. PubMed ID: 26649413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Paraná , Brazil.
    Bortoliero AL; Bonametti AM; Morimoto HK; Matsuo T; Reiche EM
    Rev Inst Med Trop Sao Paulo; 2006; 48(2):87-92. PubMed ID: 16699630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China.
    Bai MJ; Zhou N; Dong W; Li GX; Cong W; Zhu XQ
    Int J Infect Dis; 2018 Jun; 71():42-47. PubMed ID: 29656134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Burden of Hepatitis E Infection in Chronic Liver Diseases in Croatia.
    Mrzljak A; Dinjar-Kujundzic P; Jemersic L; Vilibic-Cavlek T
    Vector Borne Zoonotic Dis; 2021 Jan; 21(1):67-68. PubMed ID: 32877305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence in blood donors reveals widespread, multi-source exposure to hepatitis E virus, southern France, October 2011.
    Mansuy JM; Saune K; Rech H; Abravanel F; Mengelle C; L Homme S; Destruel F; Kamar N; Izopet J
    Euro Surveill; 2015 May; 20(19):27-34. PubMed ID: 25990359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis E in Liver Transplant Recipients in Japan.
    Inagaki Y; Oshiro Y; Tanaka T; Yoshizumi T; Okajima H; Ishiyama K; Nakanishi C; Hidaka M; Wada H; Hibi T; Takagi K; Honda M; Kuramitsu K; Tanaka H; Tohyama T; Ikegami T; Imura S; Shimamura T; Nakayama Y; Urahashi T; Yamagishi K; Ohnishi H; Nagashima S; Takahashi M; Shirabe K; Kokudo N; Okamoto H; Ohkohchi N
    EBioMedicine; 2015 Nov; 2(11):1607-12. PubMed ID: 26870785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence and risk factors of hepatitis E virus infection among children in China.
    Meng QF; You HL; Wang WL; Zhou N; Dong W; Cong W
    J Med Virol; 2015 Sep; 87(9):1573-7. PubMed ID: 25940435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological study of hepatitis E virus infection among students and workers in Hebei Province of China.
    Liu H; Geng K; Wang C; Shi T; Zhang H; Zhao C; Geng Y
    Zoonoses Public Health; 2024 Nov; 71(7):799-806. PubMed ID: 38769651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Special Risk Group for Hepatitis E Infection: The First Record of North Cyprus.
    Süer K; Güvenir M; Aykaç A
    Pol J Microbiol; 2018; 67(4):525-528. PubMed ID: 30550239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.